Residents

Siamab Therapeutics (previously Sialix)

Siamab Therapeutics (previously Sialix)

A biopharmaceutical company developing novel cancer immunotherapies.

Area of focus: 
Oncology
Graduation date: 
04/22/2015
Commencement date: 
03/01/2015

Share